Indeed, several previous studies have demonstrated increased tau plasma levels in patients with AD4–6, in a group of patients with AD and mild cognitive impairment (MCI) due to AD7 and in MCI due to AD4. The gene discussed is MAPT; the disease is Cognitive impairment.